Author Identifier (ORCID)
Abstract
The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.
Keywords
autoimmune diabetes, indigenous, latent autoimmune diabetes of adults, prevalence, type 1 diabetes
Document Type
Journal Article
Date of Publication
4-1-2025
Volume
55
Issue
4
PubMed ID
40099758
Publication Title
Internal Medicine Journal
Publisher
Wiley
School
Kurongkurl Katitjin
Funding Information
TMED was supported by a Medical Research Future Fund Practitioner Fellowship (1154192).
Funding received from the Medical Research Future Fund (MRFF)
1154192
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
First Page
659
Last Page
663
Recommended Citation
Davis, T. M., Bundell, C. S., Chubb, S. A. P., McAullay, D., & Davis, W. A. (2025). Prevalence of autoimmune diabetes among Aboriginal Australians: The Fremantle Diabetes Study Phase II. Internal Medicine Journal, 55(4), 659-663. https://doi.org/10.1111/imj.70029
Comments
Davis, T. M., Bundell, C. S., Chubb, S. A. P., McAullay, D., & Davis, W. A. (2025). Prevalence of autoimmune diabetes among Aboriginal Australians: The Fremantle Diabetes Study Phase II. Internal Medicine Journal, 55(4), 659-663. https://doi.org/10.1111/imj.70029